Sotalol Hydrochloride Tablet
Product Images NDC 71335-0260

5 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 71335-0260). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure.jpg (Figure)

Figure.jpg (Figure)
A line graph depicting the relationship between Age Factor and Age in months. The Age Factor increases progressively from 0.2 at 0.1 months to 1.0 at 24 months and beyond, with Age Factor on the vertical axis and Age in months on the horizontal axis. The graph includes grid lines and a note that Age Factor equals 1 for age greater than 24 months.*
FDA Label Image

Figure2study1.jpg (Figure2study1)

Figure2study1.jpg (Figure2study1)
A line graph titled 'P-value (Oral Sotalol vs. Placebo)' showing recurrence-free survival over time in days for different doses of oral Sotalol (80 mg, 120 mg, 160 mg) compared to placebo. The y-axis represents recurrence-free survival from 0.0 to 1.0, and the x-axis represents time in days up to 360. The graph includes P-values for each dose versus placebo using the Log-Rank test.*
FDA Label Image

Figure3study2.jpg (Figure3study2)

Figure3study2.jpg (Figure3study2)
A Kaplan-Meier survival curve chart comparing recurrence-free survival over time (days) between oral Sotalol Hydrochloride and placebo groups. The vertical axis represents recurrence-free survival probability, and the horizontal axis represents time in days up to 180 days. The curve for Sotalol Hydrochloride shows higher survival probability than placebo, with a reported P-value of 0.002 (Log-Rank test). The study endpoint is marked at 180 days.*
FDA Label Image

Structur.jpg (Structurefigure)

Structur.jpg (Structurefigure)
Chemical structure diagram of Sotalol Hydrochloride showing its molecular components including a sulfonamide group, a phenyl ring, and a hydrochloride salt form, consistent with the provided product data.*
FDA Label Image

Label Image (Lbl713350260)

Label Image (Lbl713350260)
Sotalol Hydrochloride 80 mg tablet label packaged by Bryant Ranch Prepack. The label shows storage instructions to keep the product at room temperature between 20°-25°C (68°-77°F) and to keep the package tightly closed. It compares the product to Betapace 80 mg tablets by Apotex Inc. The label includes quantity (#60), a lot number, barcode, and NDC 71335-0260.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.